Bleakley Financial Group, LLC Viatris Inc Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Viatris Inc stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 13,830 shares of VTRS stock, worth $131,385. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,830
Previous 13,471
2.66%
Holding current value
$131,385
Previous $156 Million
10.09%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VTRS
# of Institutions
1,141Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$880 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$606 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$594 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$557 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...